Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
Innervator Hall of Fame
…invest in invaluable educational initiatives and treatment-focused research. Join our action-oriented game changers by becoming a CMTA INNERVATOR. Tracy Adamson Richard Arsenault Aaron Baker David Balbi Kelly Banner James Barker…
CMTA-STAR Awards $1.1 Million for CMT1X, CMT2A Clinical Trials
…changes over shorter periods of time than self-reported measures like clinical outcome assessments so that researchers can quickly and precisely measure whether a treatment or drug had a positive impact…
Invitae Announces Major Expansion of Its Neurology Test Offerings
…better treatments and improve healthcare for everyone.” Invitae’s latest expansion of its test offering is based on the latest research findings in genetics across various panels. For example, three peer-reviewed…
Conference Recordings
…possible treatment approaches for the most common types of CMT. Genetic counselor Tanya Bardakjian shares information on the genetic mutations associated with CMT, genetic testing, inheritance patterns, and much more….
Awareness Month: A STAR Researcher’s Perspective
“What Awareness Month Means to Me” An Interview with CMTA STAR Researcher Dr. Kleopa What led you in your professional life to work on finding treatments for CMT? What really…
CMTA Alliance Partner, NMD Pharma, Announces Encouraging Data with Implications for CMT
…gravis and Charcot-Marie-Tooth disease this year.” “As we witness groundbreaking advancements in the treatment of myasthenia gravis, we’re filled with hope for the potential translational impact on CMT,” said Katherine…
How to Contact Your Hometown Media
…be identified for early treatment. Charcot-Marie-Tooth is a progressive disorder of the peripheral nerves that causes people to lose the normal use of their feet and legs. Symptoms include: foot…
Therapeutic Inactivation of CMT2 Disease Alleles with CRISPR
New technologies in gene editing such as CRISPR/Cas9 present a promising opportunity for the treatment of genetic diseases like CMT at the root cause – often just a single base…
The CMTA Is Accelerating Research Through Gene Therapy
…is to transform it into effective treatments for people living with CMT. Given the increased feasibility and applicability of gene therapy to CMT, the CMTA hosted a Gene Therapy Workshop…
CMT Type 2
…the function of the working protein and somehow treatment will need to silence that abnormal copy or cut it out. If it can be silenced, blocked or cut it out…